EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis

Nunzio Marroncelli iD, Giulia Ambrosini iD, Andrea Errico iD, Sara Vinco iD, Elisa Dalla Pozza iD, Giulia Cogo, Ilaria Cristanini iD, Filippo Migliorini, Nicola Zampieri iD, Ilaria Dando iD

Cancers · 21.07.2025 · 17 (14) · 2409

DOI: 10.3390/cancers17142409 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.07.2025. Verfasst von Nunzio Marroncelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca (MUR), Fondazione Umberto Veronesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testicular germ cell tumors (TGCTs) are the most common malignancies affecting young men between the ages of 14 and 44, accounting for about 95% of all testicular cancers. Despite being relatively rare compared to other cancers (~3.0 cases per 100,000 population, with high worldwide variability), TGCTs’ incidence is increasing, particularly in industrialized countries. The initial phase of TGCT diagnosis is performed by detecting in the blood the presence of three proteins, i.e., alpha-fetoprotein (AFP), lactate dehydrogenase (LDH), and human chorionic gonadotropin (hCG). Despite these proteins being defined as markers of TGCTs, they present limitations in specificity. Indeed, AFP is not elevated in pure seminomas; LDH serum levels can be elevated in other conditions, such as liver disease or tissue damage, and hCG can be elevated in both seminomas and non-seminomas, reducing its ability to differentiate between tumor types. However, the existence of hCG variants, characterized by distinct glycosylation profiles that are differentially expressed in TGCT types and subtypes, may increase the diagnostic and prognostic potential of this hormone. Furthermore, emerging molecular biomarkers, including miRNAs and tumor cells-related epigenetic status, may offer new promising alternatives to improve diagnostic accuracy. Nonetheless, standardized diagnostic protocols still need to be implemented. Finally, understanding the biological roles of hCG isoforms and their “canonical” (e.g., LHCGR) and “non-canonical” (e.g., TGF-βR) receptor interactions may help in understanding tumor biology and therapeutic targeting.

Schlagwörter

Stichwörter der Autor:innen

cancer biomarkerdiagnostic markerhCGhormonesmale cancertesticular germ cell tumors

Autor:innen und Institutionen

  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
  • UOC of Urology, Azienda Ospedaliera Universitaria Integrata di Verona, 37126 Verona, Italy.
  • Department of Engineering and Innovation Medicine, Paediatric Fertility Lab, Woman and Child Hospital, Division of Pediatric Surgery, University of Verona, 37126 Verona, Italy.
  • Saint Camillus International University of Health Sciencies (UniCamillus), 00131 Rome, Italy.

ORCID-Profile: Nunzio Marroncelli, Giulia Ambrosini, Andrea Errico, Sara Vinco, Elisa Dalla Pozza, Ilaria Cristanini, Nicola Zampieri, Ilaria Dando

Förderung

  • Ministero dell'università e della ricerca
  • Ministero dell’Istruzione, dell’Università e della Ricerca (MUR)
  • Fondazione Umberto Veronesi
  • Lions Clubs International-Isola della Scala
  • Bovolone and Villafranca di Verona (Italy)

Zitieren

APA

Marroncelli, N., Ambrosini, G., Errico, A., Vinco, S., Dalla Pozza, E., Cogo, G., Cristanini, I., Migliorini, F., Zampieri, N., & Dando, I. (2025). Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis. Cancers, 17(14), 2409. https://doi.org/10.3390/cancers17142409

Vancouver

Marroncelli N, Ambrosini G, Errico A, Vinco S, Dalla Pozza E, Cogo G, et al. Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis. Cancers. 2025;17(14):2409. doi:10.3390/cancers17142409

BibTeX
@article{Marroncelli2025,
  author = {Marroncelli, Nunzio and Ambrosini, Giulia and Errico, Andrea and Vinco, Sara and Dalla Pozza, Elisa and Cogo, Giulia and Cristanini, Ilaria and Migliorini, Filippo and Zampieri, Nicola and Dando, Ilaria},
  title = {Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {14},
  pages = {2409},
  doi = {10.3390/cancers17142409}
}
Kostenlos starten →